PMID: 30819992Mar 2, 2019Paper

Capillary versus Serum b-hydroxybutyrate in Pediatric Diabetic Ketoacidosis

Indian Pediatrics
Praveen M KurupPonnarmeni Satheesh

Abstract

To find the strength of agreement between point-of-care and serum b-hydroxybutyrate. 236 paired samples (capillary b-hydroxybutyrate by a point of care device and serum b-hydroxybutyrate by colorimetric enzymatic estimation) samples were collected from 26 children aged <13 years admitted with diabetic ketoacidosis. Inborn errors of metabolism and septic shock were excluded. Capillary b-hydroxybutyrate showed excellent agreement with serum â-hydroxybutyrate with mean (SD) bias of 0.027 (0.78); 95% limit of agreement -1.51, 1.56 and intraclass correlation 96.1% (95%CI 95%-97%, P<0.001). An increase in the bias noted for value above 5 mmol/L (P<0.001) (serum measurements were higher than capillary point-of-care measure-ments). Capillary â-hydroxybutyrate correlated significantly with blood pH, anion gap,bicarbonate and carbon dioxide levels on blood gas analysis (P<0.05). Capillary b-hydroxybutyrate estimation is a valid method for monitoring of ketonemia in pediatric diabetic ketoacidosis.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
T KusunokiA Kinugasa
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Sarah LawrenceDenis Daneman
The Journal of the South Carolina Medical Association
Robert S SeiglerDarryl R Gwyn
Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
M BlumM Strat
© 2022 Meta ULC. All rights reserved